The symptom relief seen with an enlarged prostate (BPH) is most commonly sought with saw palmetto. This is a standardized extract from the fruit of Serenoa repens and contains fatty acids and phytosterols that are thought to modulate prostate biology, including potential inhibition of 5-alpha-reductase and anti-inflammatory effects. In practice, many men report modest improvements in urinary symptoms such as frequency, nocturia, urgency, and flow, though study results are variable and the effect size is generally smaller than prescription therapies. Saw palmetto is usually well tolerated, with mild gastrointestinal upset or headaches being the most common side effects; be mindful of possible interactions with anticoagulants or antiplatelet medications and with other systemic drugs, and ensure use of a standardized product for consistent dosing. Other herbs listed have different primary uses (for example, mood or immune support) and are not established to improve BPH symptoms, which is why saw palmetto remains the herb most frequently used for this purpose.

Severe diarrhea causes loss of bicarbonate in the intestinal fluid. Bicarbonate is a base used to buffer hydrogen ions; when it’s lost in stool, the serum bicarbonate concentration falls and the blood becomes more acidic, producing metabolic acidosis. Most cases present as a non-anion gap (hyperchloremic) metabolic acidosis, because the loss of base is balanced by an increase in chloride to maintain electroneutrality. The body attempts to compensate by increasing respiratory rate to blow off CO2, which helps raise pH somewhat. This differs from metabolic alkalosis, which comes from loss of acid (for example, from vomiting or certain diuretics) and would raise pH. Respiratory acidosis would require hypoventilation with CO2 retention, not a primary GI bicarbonate loss.

St. John’s Wort is best known for its antidepressant effects. The active components, such as hyperforin and hypericin, are thought to increase the availability of mood-regulating neurotransmitters—serotonin, norepinephrine, and dopamine—by reducing their reuptake. This mechanism supports its use in mild to moderate depression, which is the condition it’s most commonly noted to help aside from any other uses. The other listed conditions (hypertension, asthma, osteoporosis) do not have established therapeutic benefit from St. John’s Wort in standard practice. It’s also important to remember that this herb can interact with many medications by inducing liver enzymes, potentially reducing the effectiveness of anticoagulants, birth control, SAMPLEimmunosuppressants, and some antidepressants, among others.

Cerebral perfusion pressure is the driving force for blood flow to the brain and is calculated as mean arterial pressure minus intracranial pressure. After a cerebrovascular accident, maintaining an adequate CPP is essential to ensure brain tissue receives enough blood, especially if ICP is high or autoregulation is impaired. Raising the mean arterial pressure through IV fluids to increase intravascular volume and using hypertensive therapy to elevate systemic blood pressure directly raise the driving pressure pushing blood into the brain. This approach improves CPP even when ICP is elevated, helping to preserve cerebral perfusion. Other strategies mainly affect ICP or CBF in ways that don’t reliably increase CPP. Elevating the head and providing sedation can reduce ICP, but they may lower MAP and thus not improve CPP. Diuretics lower ICP by reducing volume but can decrease intravascular volume and BP, potentially reducing CPP. Hyperventilation reduces ICP by causing cerebral vasoconstriction and lowering cerebral blood volume, but it also lowers cerebral blood flow and CPP, making it less suitable for increasing CPP except in acute, emergent situations. So the best approach to increase cerebral perfusion pressure after a cerebrovascular accident is boosting mean arterial pressure with IV fluids and careful hypertensive management.

In HIV care, the goal of antiretroviral therapy is to suppress viral replication to a level that minimizes disease progression and transmission. The threshold described here—less than 5,000 copies per milliliter—reflects a level of suppression that is considered effective in many clinical contexts and serves as a practical target when ultra-sensitive testing isn’t available or when looking for a clear, achievable marker of good response. It shows substantial control of the virus, distinguishing it from higher viral loads that indicate poorer control and potential treatment failure. While lower targets (such as undetectable levels) are ideal in many guidelines, the scenario described uses the 5,000 copies/mL threshold as the stated goal. Levels below 50 copies/mL or 5 copies/mL are closer to undetectable, which is more stringent than the threshold described, and a threshold like 100,000 copies/mL would indicate poor control and would not be considered a favorable target.